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ABSTRACT 
Objective: To investigate the hepatoprotective activity of ethanolic stem bark extract (ESBE) of Knema attenuata against carbon tetrachloride (CCl4) 
induced hepatotoxicity in Wistar rats using both in vivo and in vitro models. 
Methods: Animals were treated orally with ESBE (250 mg kg-1 and 500 mg kg-1) once daily for 6 d and CCl4 on the 4th d. On the 7th d, animals were 
sacrificed and the blood samples were collected to measure the serum levels of biochemical parameters, whereas the liver homogenates were 
utilized for estimating the antioxidant defense. The hepatoprotective efficacy of the extract was further ensured in vitro using human liver 
hepatocellular carcinoma (HepG2) cell line against CCl4 induced toxicity. The cell line viability was determined using 3-(4,5-dimethyl thiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT) assay. 
Results: ESBE effectively reduced (p<0.001) the elevated serum levels of Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), and 
Alkaline phosphatase (ALP) when compared to the toxicant control group. ESBE 500 mg kg-1significantly raised the antioxidant defense (p<0.0001) 
by reducing the malondialdehyde (MDA) level and enhancing hepatic reduced glutathione (GSH) level in comparison to the CCl4 control group. The 
in vitro effect was investigated using CCl4 exposed HepG2 cells. Pretreatment with ESBE showed a dose-dependent increase in percentage cell 
viability ranged between 44 to 57% at 12.5-100 μg ml-1concentrations (p<0.001, when compared to the control cells).  
Conclusion: Present study confirms the hepatoprotective activity of the stem bark extract of K. attenuata against CCl4-induced liver damage.  
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INTRODUCTION 
The liver, a vital internal organ of the human body, is involved in 
detoxification and excretion of a majority of xenobiotics, which may 
cause potential harm to the body. Since it is involved in the 
biochemical conversions of various endogenous and exogenously 
administered or ingested substances, highly reactive free radical 
species may generate [1, 2]. It has an inbuilt protective mechanism 
(antioxidants) to neutralize them. However, the imbalance in the 
liver caused by the difference in the production of free radicals and 
their elimination by protective mechanisms leads to liver toxicity or 
damage. During liver damage, free radicals can induce the 
generation of Pro-inflammatory genes, whose over-expression 
triggers an intracellular signaling cascade that leads to the 
production of more free radicals. These pathways could result in 
enhanced oxidative stress and inflammatory lesions, which promote 
the pathogenesis of liver diseases [3]. Continuous exposures 
towards environmental toxins, poor drug habits, and alcohol, can 
exaggerate the condition, which eventually leads to liver diseases 
such as hepatitis and jaundice. Due to the adverse effects produced 
by allopathic medicine, the development of effective therapies using 
herbal preparations is preferred to treat liver ailments [4]. 
CCl4 induced hepatotoxicity; a free radical-mediated cytotoxic model 
is widely employed for the screening of hepatoprotective activity of 
compounds. The changes associated with CCl4 induced liver damage 
to resemble that of acute viral hepatitis [5]. 
K. attenuata, which belongs to Myristicaceae family, is an endemic tree 
species native to south India extending from Konkan southwards of 
Maharashtra, Goa, Karnataka, Tamil Nadu, and Kerala [6]. The species 
has been used in folk medicine as an ingredient of ayurvedic 
‘Ashwagandhadi nei’, for the treatment of conditions like spleen 
disorders, breathing disorders, and impaired taste sensation. The stem 
bark is also being used in the form of decoction for the treatment of 
jaundice and chronic fever [7]. Studies on the stem bark of K. attenuata 
reported the presence of a lignan attenuol; closely related to those 
isolated from the plants of Myristicaceae family, which are known to 
possess antioxidant, liver protection, anti-inflammatory and anti-
cancerous properties [8, 9]. Antioxidant, anti-inflammatory, and 
antimicrobial properties of ethanolic extract of stem bark of K. 
attenuata have already been reported [10-12]. However, there is no 
scientific work has been performed so far on the hepatoprotective 
activity of the plant. Therefore, the present study was designed to 
evaluate the hepatoprotective properties of the ethanolic stem bark of 
K. attenuata using both in vivo and in vitro screening techniques. 
MATERIALS AND METHODS 
Collection of plant material 
The stem bark of K. attenuata for the proposed study was collected from 
Kerala Forest Research Institute, Peechi, Thrissur in January 2015. The 
identification and authentication of species were carried out by Dr. V. B 
Sreekumar, Scientist (Botany Department), Kerala Forest Research 
Institute, Peechi, Thrissur. The fresh stem barks were collected, 
thoroughly washed, spread in trays, and air-dried for three w. The 
cleaned and air-dried barks were subjected to coarse powdering and 
sieved (sieve no: 44) to obtain a uniform size for extraction [13]. 
Preparation of extract 
A 50 g of dried stem bark powder of K. attenuata was packed in a 
thimble and loaded in a soxhlet apparatus. After defatting stem bark 
powder with petroleum ether (60-80 °C), it was subjected to 
continuous extraction with 300 ml of 95 % ethanol to get an ethanolic 
fraction. The filtrate was evaporated to vacuum (at 40 °C) to obtain the 
dried ESBE with a percentage yield of 17.8% w/w. The extract was 
solubilized using water to feed rats in subsequent studies [14]. 
Drugs and chemicals 
HepG2 cell lines were purchased from the National Centre for Cell 
Sciences, Pune. Silymarin and Thiobarbituric acid (TBA) were 
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purchased from Sigma chemicals, USA. Dulbecco’s modified eagle’s 
medium and Trypsin-EDTA solution were procured from Himedia 
laboratories, Mumbai. Commercial kits used for determining 
biochemical parameters were obtained from Agappe Diagnostics 
Ltd, Kerala. All chemicals and reagents used were of analytical grade. 
Animals 
In this study, Wistar rats of either sex (150-250 g), were procured from 
the animal house (Reg No: 752/02/a/CPCSEA) of Govt. Medical College, 
Trivandrum. The animals were housed in propylene cages (3 per cage) 
with dust-free husk as bedding material under standard condition of 
temperature (25±2 °C) and relative humidity (30-70 %) with a 12:12 
light-dark cycle and fed with standard rodent pellet and water except 
during experimentation. Institutional Animal Ethics Committee, Govt. 
Medical College, Thiruvananthapuram, approved the experimental 
protocols on 17/12/2014 (Approval no: 03/13/2014/MCT). 
Cell culture 
HepG2 hepatic carcinoma cell lines were maintained in Dulbecco’s 
modified eagle’s media supplemented with 10% Fetal bovine serum 
(FBS) and grown to confluency at 37 °C in 5 % CO2 in a humidified 
atmosphere in a CO2 incubator.  
Acute toxicity studies 
Acute oral toxicity test was carried out as per the Organization for 
Economic Co-operation and Development (OECD) Guidelines for 
the testing of Chemicals number 425. Since there was little 
information about the toxicity of extract, the main test was 
performed. All the animals were observed 14 d for any sign of 
toxicity and mortality [15]. 
Hepatoprotective activity 
Wistar rats of either sex (150-250 g) were randomly divided into 5 
groups with each group consisting of 6 animals. Animals of group1 
served as control and were given only vehicle (water) for 6 d, 
animals of group 2 served as toxin control and were administrated 
with CCl4 (in liquid paraffin, 1 ml kg-1 orally) on 4th d and with the 
vehicle on rest of the d. Animals of group 3 received standard drug of 
silymarin (100 mg kg-1, orally) for 6 d orally as well as CCl4 (1 ml kg-
1) on 4th d. Animals of group 4 and group 5 received ESBE 250 mg kg-
1, ESBE 500 mg kg-1for 6 d orally, and CCl4 (1 ml kg-1) on 4th d. 
On 7th d, animals were sacrificed by cervical dislocation. The blood 
was collected by cardiac puncture of each animal and serum was 
separated, which was analyzed for assessment of enzyme activity. 
After collecting blood from each animal, the liver was separated, 
washed with ice-cold PBS and soaked in filter paper. Liver tissue was 
minced; added 5 ml ice-cold PBS and was homogenized in tissue 
homogenizer at 4000 rpm for 5 min and then centrifuged at 5000 
rpm for 5 min. The clear supernatant was stored at 4 °C until use 
[16, 17]. 
Estimation of serum biochemical parameters 
Serum biochemical parameters were estimated according to standard 
methods. The activity of the enzymes ALT, AST, and ALP was measured 
using commercial enzymatic biochemical diagnostic kits. 
Estimation of tissue biochemical parameters 
a) Lipid peroxidation 
The extent of lipid peroxidation in the liver was determined in 
supernatant of liver tissue homogenate following standard 
methodology [18]. The amount of MDA was measured by reaction 
with TBA at 532 nm and the MDA level was expressed as nmol mg-1 
protein. 
b) Estimation of GSH levels 
GSH level was estimated according to the method described by 
Ellman GL [19]. The sulfhydryl group of GSH reacts with DTNB (5,5’-
dithio-bis-2-nitrobenzoic acid, Ellman’s reagent) and produces a 
yellow colored 5-thio-2-nitrobenzoic acid (TNB) with a maximum 
absorbance at 412 nm. The results were expressed as nmol mg-1 
protein. 
In vitro hepatoprotective activity against CCl4 induced HepG2 
cell toxicity 
HepG2 hepatic carcinoma cells were trypsinized (500 µl of 0.025% 
Trypsin in PBS/0.5 mmol EDTA solution) for 2 min and transferred 
to T flasks in complete aseptic conditions. 200 µl of the cell 
suspension was plated into a 96-well culture plate and incubated for 
24 h. Post incubation, the cells were treated with different fractions 
of ESBE at a concentration ranging from (12.5–100 μg ml-1) for 24 h, 
to investigate the possible toxic effect. MTT assay was employed to 
measure cell viability. Later, for studying the hepatoprotective 
activity, cells were pretreated with different fractions of ESBE and 
incubated for 2 h. Then CCl4 (0.1%) was added to the wells and kept 
for 24 h. Untreated cells were kept as control. Thereafter, the 
viability of HepG2 cells was estimated by MTT reduction assay [20]. 
MTT assay 
The cells were washed with 1x PBS and then added 30 µl of MTT 
solution to the culture (MTT-5 mg ml-1 dissolved in PBS). It was then 
incubated at 37 °C for 3 h. MTT was removed by washing with 1x 
PBS and 200 µl of DMSO was added to the culture. Incubation was 
done at room temperature for 30 min until the cell got lysed and the 
color was obtained. The solution was transferred to centrifuge tubes 
and centrifuged at top speed for 2 min to precipitate cell debris. 
Optical density was read at 540 nm using DMSO as blank in a 
microplate reader [17, 21]. 
V% =   
(ODt −   ODb) 
(ODc  −  ODb)
    × 100  
Where, V% is percentage cell viability; ODt is the optical density of 
treated cells; ODb is optical density of blank cells; and ODc is optical 
density of control cells.  
Statistical analysis 
The obtained data were analyzed by one-way ANOVA followed by 
Dunnet’s t-test and p<0.05 was considered statistically significant.  
RESULTS 
Acute toxicity studies 
Neither toxic symptoms nor mortality was observed throughout the 
observation period even at the highest dose (5000 mg kg-1) 
indicating low toxicity of extract. There were also no significant 
changes in food consumption, water uptake, and body weight 
observed in animals after treatment with the stem bark extract of K. 
attenuata. Additionally, the histopathological analysis of vital organs 
(data not shown) also didn’t show statistically significant changes 
upon the treatment. The results imply that (supported by results 
from AOT425 stat program version 1.0) that the oral lethal dose 
(LD50) of K. attenuata is greater than 5000 mg ml-1. 
Hepatoprotective effect of ESBE in CCl4-induced liver damage 
Effect of ESBE on liver function parameters 
Hepatic injury by CCl4 was confirmed by measuring the activity of 
hepatic marker enzymes ALT, AST, and ALP of rats intoxicated by 
CCl4. A significant increase in the levels of ALT, AST, and ALP was 
observed in CCl4–treated rats from those of the control group (fig. 1). 
Administration of ESBE (250 mg kg-1 and 500 mg kg-1) significantly 
attenuated the elevation of these parameters in a dose-dependent 
manner. The hepatoprotective effect shown by ESBE was almost 
comparable to that of silymarin. 
Effect of ESBE on liver oxidative status 
As illustrated in table 1, the MDA level was significantly increased in 
the CCl4 group as compared to the control group. Silymarin 100 mg 
kg-1 showed significant protective activity against CCl4-mediated 
lipid peroxidation. Pretreatment of rats with ESBE at doses of 250 
and 500 mg kg-1 also caused a significant diminution of elevated 
MDA level, indicating that ESBE could effectively inhibit the lipid 
peroxidation induced by CCl4. Besides, the decrease in the content of 
GSH caused by CCl4 was effectively reversed by ESBE in a dose-
dependent manner. 
 
Fig. 1: Effects of ESBE of K. attenuata on serum levels of ALT
error of the mean. Silymarin 100 mg kg-1, ESBE 
by Dunnett’s t
Fig. 2: Effects of ESBE of K. attenuata on serum levels of AST
error of the mean. Silymarin 100 mg kg-1, ESBE 250 mg kg
by Dunnett’s t-test. Silymarin 100 mg kg-1, ESBE 250 mg kg
Fig. 3: Effects of ESBE of K. attenuata on serum levels of ALP
error of the mean. Silymarin 100 mg kg-1, ESBE 250 mg kg
by Dunnett’s t
Table 1: Determination of oxidative stress in liver homogenate, n=6; Values were expressed in 
****
Group GSH (nmol mg-1 
Group 1 147.93±23.71 
Group 2 74.76±7.15 
Group 3 138.89±6.07*** 
Group 4 113.17±2.52**** 
Group 5 129.61±3.14**** 
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In vitro hepatoprotective activity using HepG2 cell lines
The exposure of HepG2 cells to varying concentrations of ESBE of 
attenuata alone for 24 h did not alter the viability (
toxicant administration, the CCl4 exposed cells showed the 
percentage viability of 22.49 %. These exposed cells
Fig. 4: Effects of ESBE of K. attenuata on
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Natural products isolated from medicinal plants
significance and immense popularity in the 
system. Herbal drugs, which offer protection from hepatic 
disturbances or help in the regeneration of hepatic cells
hepatoprotective agents. These drugs contain a variety of chemical 
constituents like phenols, coumarins, curcuminoids, lignans
essential oils, and terpenoids [22]. The present study demonstrates 
the effect of ESBE as a possible hepatoprotective agent.
According to the guidelines recommended by OECD,
testing of crude ESBE was carried out to find the safety profile
LD50 value for the extract based on which dose for further studies can 
be selected. As per the study, LD50 value was obtained as greater than 
5000 mg kg-1, indicating that the extract was relatively non
Two doses 250 mg kg-1 and 500 mg kg-1 were selected for
the screening of hepatoprotective activity. 
CCl4 is a hepatotoxic compound that causes severe hepatic injury.
The compound undergoes metabolism by the action of 
cytochrome p 450 forming unstable and highly reactive 
such as tri-chloro-methyl (CCl3-) and tri-chloro
radical (CCl3OO−). Hepatotoxicity induced by CCl
of these free radicals, which alters the permeability of 
membrane, causing leakage of liver enzymes such as ALT, AST
ALP into the blood circulation. Therefore, elevated levels of these 
liver enzymes are important biomarkers that indicate hepatotoxicity 
or injury to the liver [23, 24]. Pre-treatment with 
introduction of CCl4 has shown a promising dose
potential to restrain the elevated level of liver enzymes in 
Free radicals generated by CCl4 induce substantial oxidative stress 
and attack polyunsaturated hepatic membrane lipids causing lipid 
peroxidation. The end products of this oxidation are MDA
hydroxynonenal, and 4-hydroxy-2, 3-alkenals
obtained indicated elevated MDA levels in the liver 
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fig. 4). Upon 
, when treated 
with different concentrations of extract, a dose
in percentage viability that ranged between 44.
observed, indicating that pre-treatment
prevented cell death in a concentration
results of cell viability are depicted in
 
 
 HepG2 cell viability. n=3; values were expressed in mean
 
, an average of 3 determinations, carried out in triplicates, 
standard error of the mean, ***p<0.001 compared to control group
 Percentage cell viability
 100 
4(0.1%) 22.49±0.871 
4 with Silymarin 100 μg ml-1 80.35±2.05 
4 with ESBE 12.5 μg ml-1 44.33±1.21*** 
4 with ESBE 25 μg ml-1 45.25±2.61*** 
4 with ESBE 50 μg ml-1 52.08±1.77*** 
4 with ESBE 100 μg ml-1 57.41±2.33*** 
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 [25]. The results 
as a response to 
CCl4 treatment, implying enhanced oxidative
However, the results also suggested that the treatment of CCl
intoxicated rats with ESBE caused 
back to their control levels in the serum.
Glutathione is an antioxidant capable of scavenging free radicals and 
thereby inhibiting the chain reaction of lipid peroxidation.
Glutathione can exist in both reduced (GSH) and oxidized (GSSG) 
states. The sulfhydryl residues of GSH molecule get
which in turn, can be converted back to GSH using glutathione 
reductase (GR). The redox ratio of GSH/GSSG within cells is a 
measure of cellular oxidative stress. 
hepatic GSH level indicates the extent of oxidative injury to
[26]. The intoxication with CCl
and functioning of GSH; however, the administration of ESBE 
reverses this, suggesting a protective effect. 
antioxidant activity by decreasing the extent of lipid peroxidation 
and maintaining the glutathione level
oxidative stress. 
HepG2 cell line is considered as 
the hepatoprotective potential of phyto compounds as they possess
functional similarity to normal human hepatocytes
investigation carried out on HepG2 cells against CCl
damage also confirmed the hepatoprotective nature of 
indicating a good correlation between 
Phytoconstituents like the phenolic compounds and flavo
reported to be present in ESBE,
activity [10]. The mechanism of 
ethanolic extract of stem bark of
antioxidant potential. ESBE can reduce free radicals
the oxidative damage to the hepatocytes and improve the activities of 
the liver antioxidant enzymes, thus protecting the liver from CCl
induced damage. Its hepatoprotective
presence of flavonoids and polyphenolic compounds identified in 
preliminary phytochemical analysis of extract.
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The stem bark of K. attenuata has been used in folk medicine for the 
treatment of liver disorders. The present study on ESBE of K. 
attenuata shows promising hepatoprotective activity in both in vitro 
and in vivo studies and thereby provides proper scientific evidence 
for its traditional use. The study also reaffirms its antioxidant 
activity, which is due to the presence of flavonoids and phenolic 
compounds. Therefore, it can also be useful in several diseases that 
cause oxidative stress. Further work is in progress to isolate and 
characterize the active constituents responsible for the various 
pharmacological activities of stem bark of K. attenuata. 
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